Latest Medical News
Generic Copaxone for MS Passes Clinical Test
BOSTON -- A copycat version of the multiple sclerosis drug Copaxone, known generically as glatiramer acetate, performed similarly to the original product in a head-to-head trial, paving the way for it to win regulatory approval as a generic drug.
Sep 12, 2014
Novel Drug Beats Avonex for MS Efficacy; Safety Still a Worry
BOSTON -- Daclizumab HYP cut relapse rates and disability progression in multiple sclerosis patients more effectively than interferon beta-1a (Avonex) in a phase III trial, but liver toxicity with the IL-2 inhibitor reared its head again.
Sep 12, 2014
Ebola Response: Slowed by a 'Perfect Storm' of Setbacks
WASHINGTON -- The world was taken by surprise by the West Africa Ebola outbreak and has been scrambling ever since to catch up, with many setbacks and only a few bright spots in the picture, international experts said at the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Sep 08, 2014
ESC: Will CvLPRIT Change Practice?
BARCELONA -- Cardiologists react to findings from the CvLPRIT study, which challenge not only traditional thinking but also existing guidelines from both the U.S. and Europe, all of which say that treating nonculprit arteries in STEMI patients may be harmful.
Sep 03, 2014
ESC: Mixed Results with Steroids in TB Pericarditis
BARCELONA -- Adding steroids to anti-tuberculosis treatment for patients with tuberculous pericarditis can reduce the risk of complication and the resulting hospital admission, but adding prednisolone to tuberculosis treatment did not reduce the risk of death, researchers said here.
Sep 03, 2014